Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum10on Jan 10, 2025 7:02am
59 Views
Post# 36397356

RE:RE:RE:RE:RE:Evolving business

RE:RE:RE:RE:RE:Evolving business
CADInvestor12 wrote:

Fair enough, you're not wrong about how the revenue ramp up will take time. I thought you were referring to initial shipments/ pipeline fill. I have a hunch that Q1 revenue in Brazil will be around $2M, obviously depending on when the import/ export permits are received .. MPL & Teuto should be ready to hit the ground running since this launch is at least 2 quarters behind schedule due to regulatory delays and Brazil is a less saturated market vs other Int'l markets (Germany/ Australia), I'm optimist 



Given the total market size is $200M and given, I assume, that addressable market of Medipharm is much less, $2M in one quarter represents far too large of a market share grab.  Granted they might ramp up in that first quarter, but subsequent ones I wouldn't expect to be anywhere near the size of the first one.  Since we don't know what market segment Medipharm will participate in and how many participants there are there, it's not realistic to presume whether the market is saturated or not. 
<< Previous
Bullboard Posts
Next >>